688513.SH
Chengdu Easton Biopharmaceuticals Co., Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 42.91
−5.82%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 30.72x
- P/E 2027E
- 27.84x
- P/E 2028E
- 24.60x
- P/S forward
- 25.77x
Trailing multiples
Trailing twelve months
- P/E TTM
- 26.67x
- PEG TTM
- —
- Price / book
- 2.58x
- Price / sales
- 6.34x
- Price / cash flow
- 27.50x
Enterprise value
- Enterprise value
- CNY 8.4B
- EV / sales
- 6.23x
- EV / EBITDA
- 20.59x
- EV / EBIT
- 28.11x
- Market cap
- CNY 7.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026